268557-85-3

Upstream product

• 10472-24-9 methyl 2-oxocyclopentane-1-carboxylate 
• 87753-09-1 2-(3-chlorophenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-ol 

Downstream Products

• 1621294-16-3 4-(2-(3-chlorophenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-ylamino)benzoic acid 
• 1606973-04-9 2-[4-[[2-(3-chlorophenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]amino]phenyl]acetic acid 
• 1621294-57-2 4-(2-(3-chlorophenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-ylamino)benzoic acid methyl ester 
• 1606973-63-0 (2-(3-chlorophenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)(p-tolyl)methanone 
• 1606974-70-2 4-((2-(3-chlorophenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)amino)butanamide 
• 1606976-50-4 2-(3-chlorophenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidine-4-carbonitrile 
• 1606973-62-9 2-(3-chlorophenyl)-4-(4-methylbenzyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidine 
• 1606976-49-1 methyl 2-(4-((2-(3-chlorophenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)methyl)phenyl)acetate 

Relevant academic research and scientific papers

4-AMINO SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS AS PDE4 INHIBITORS

The invention relates to novel substituted condensed pyrimidine compounds of general formula (I) in which the chemical groupings, substituents and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.